Royalty Pharma reports Q4 results [Seeking Alpha]
Royalty Pharma plc - Class A Ordinary Shares (RPRX)
US:NASDAQ Investor Relations:
ir.reprosrx.com/investor-relations
Company Research
Source: Seeking Alpha
Full year 2026 guidance: Portfolio Receipts expected to be $3,275 million to $3,425 million Newsletters for Every Investor Get daily, sector-specific newsletters packed with expert insights, fresh ideas, and new opportunities. Subscribe to Newsletters Sign Up More on Royalty Pharma Royalty Pharma plc (RPRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Royalty Pharma plc (RPRX) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Royalty Pharma plc (RPRX) Presents at Evercore 8th Annual Healthcare Conference Transcript Royalty Pharma Q4 2025 Earnings Preview Royalty Pharma promises $500M to Teva for advancing vitiligo treatment
Show less
Read more
Impact Snapshot
Event Time:
RPRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RPRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RPRX alerts
High impacting Royalty Pharma plc - Class A Ordinary Shares news events
Weekly update
A roundup of the hottest topics
RPRX
News
- Royalty Pharma plc (RPRX) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Royalty Pharma targets 3%–8% royalty receipts growth in 2026 while advancing $4.7B in transactions [Seeking Alpha]Seeking Alpha
- Royalty Pharma Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Royalty Pharma (NASDAQ:RPRX) Reports Sales Below Analyst Estimates In Q4 CY2025 Earnings [Yahoo! Finance]Yahoo! Finance
- Royalty Pharma: Q4 Earnings Snapshot [Yahoo! Finance]Yahoo! Finance
RPRX
Sec Filings
- 2/11/26 - Form 10-K
- 2/11/26 - Form 8-K
- 2/4/26 - Form 4
- RPRX's page on the SEC website